Yuyu Pharma, Inc. (KRX:000220)
South Korea · Delayed Price · Currency is KRW 4,140.00
-25.00 (-0.60%)
Last updated: Nov 25, 2025, 2:49 PM KST
Yuyu Pharma Market Cap
Yuyu Pharma has a market cap or net worth of 66.2 billion as of November 26, 2025. Its market cap has decreased by -7.23% in one year.
Market Cap
66.20B
Enterprise Value
80.06B
Revenue
139.51B
Ranking
n/a
PE Ratio
14.58
Stock Price
4,140.00
Market Cap Chart
Since August 31, 1995, Yuyu Pharma's market cap has increased from 11.10B to 66.20B, an increase of 496.26%. That is a compound annual growth rate of 6.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 66.20B | -9.19% |
| Dec 30, 2024 | 72.90B | -14.68% |
| Dec 28, 2023 | 85.44B | -16.84% |
| Dec 29, 2022 | 102.75B | -21.01% |
| Dec 30, 2021 | 130.08B | 20.22% |
| Dec 30, 2020 | 108.20B | 62.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.32T |
| Celltrion | 39.84T |
| ALTEOGEN | 27.70T |
| SK Biopharmaceuticals | 10.10T |
| ABL Bio | 9.54T |
| Yuhan | 8.55T |
| Peptron | 7.43T |
| LigaChem Biosciences | 6.25T |